Physician profile
Paul R Eber
NPI 1124085634
$476,064.93
in general payments reported to CMS, 2019-2025
60 companies · $71K in 2025
The $71K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $40K · 2021: $46K · 2022: $101K · 2023: $95K · 2024: $56K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $176K · Travel and Lodging: $24K · Food and Beverage: $8,955 · Consulting Fee: $8,789 · Honoraria: $4,080 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $176,134.43 |
| Travel and Lodging | $24,102.73 |
| Food and Beverage | $8,954.84 |
| Consulting Fee | $8,788.85 |
| Honoraria | $4,080.00 |
| Education | $178.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $124,278.41 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $117,615.88 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $94,358.62 | 2019-2025 | |
| Janssen Biotech, INC. | $68,642.03 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Pfizer INC. | $33,071.99 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $19,134.76 | 2020-2025 | Lynparza, Imfinzi |
| Urogen Pharma, INC. | $5,476.91 | 2020-2025 | |
| Avyxa Pharma, LLC | $3,370.70 | 2025 | |
| Janssen Scientific Affairs, LLC | $2,074.29 | 2022-2025 | Erleada, Akeega |
| Exelixis INC. | $1,470.00 | 2021 | |
| Sumitomo Pharma America, INC. | $903.97 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $584.67 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $475.52 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $445.25 | 2020-2025 | Botox, Lupron Depot |
| Novartis Pharmaceuticals Corporation | $417.77 | 2020-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $394.46 | 2019-2025 | Adstiladrin |
| Amgen INC. | $312.13 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $248.91 | 2019-2025 | Yonsa |
| Myovant Sciences INC. | $244.93 | 2021-2022 | |
| Boston Scientific Corporation | $231.90 | 2020-2022 | |
| Teleflex LLC | $206.09 | 2024-2025 | Barrigel |
| Allergan, INC. | $182.28 | 2019-2022 | |
| Medtronic USA, INC. | $159.52 | 2020 | |
| Angiodynamics, INC. | $151.40 | 2024 | Nanoknife |
| I/O Urology Corp. | $149.83 | 2024 | Carepath |
| Verity Pharmaceuticals INC. | $131.86 | 2022-2024 | Trelstar, Tlando |
| Calyxo, INC. | $125.93 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $112.87 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $104.36 | 2022-2024 | Prolaris |
| Progenics Pharmaceuticals, INC. | $97.76 | 2023 | Pylarify |
| Telix Pharmaceuticals | $81.47 | 2024-2025 | Illuccix |
| Accord Healthcare, INC. | $76.24 | 2025 | |
| Axonics, INC. | $64.27 | 2020-2024 | Bulkamid |
| Tolmar, INC. | $62.64 | 2023-2025 | Eligard, Jatenzo |
| Intuitive Surgical, INC. | $52.30 | 2024 | |
| Laborie Medical Technologies Corp. | $52.19 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $48.65 | 2022 | |
| Antares Pharma, INC. | $48.38 | 2019-2024 | Xyosted |
| Mission Pharmacal Company | $35.25 | 2019-2020 | |
| Procept Biorobotics Corporation | $32.47 | 2024 | Aquabeam System |
| Avadel Specialty Pharmaceuticals, LLC | $26.04 | 2019 | |
| Conmed Corporation | $25.25 | 2024 | Airseal |
| Medtronic, INC. | $24.12 | 2023 | Signia |
| Endo USA, INC. | $23.17 | 2024 | Xiaflex |
| Travere Therapeutics, INC. | $21.72 | 2021 | |
| Davol INC. | $21.06 | 2024 | Arista Ah Flexitip |
| Clarus Therapeutics INC. | $20.96 | 2021 | |
| Hollister Incorporated | $18.47 | 2024 | |
| Abc Home Medical Supply, INC. | $18.47 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $17.80 | 2024 | |
| Tempus Ai, INC | $16.01 | 2024 | Xt Cdx |
| Foundation Medicine, INC. | $15.81 | 2023 | |
| Therapeuticsmd, INC. | $14.94 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $14.49 | 2020 | |
| Sandoz INC. | $14.33 | 2025 | Jubbonti, Wyost |
| Ambu INC. | $12.61 | 2020 | |
| Coloplast Corp | $12.38 | 2021 | |
| Valencia Technologies Corporation | $9.90 | 2025 | Ecoin Device Kit |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Eber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.